United Kingdom · Question · Written question
UIN 97463
Puberty Suppressing Hormones: Clinical Trials
Introduced
4 December 2025
Last action
13 January 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
13 January 2026
Summary
To ask the Secretary of State for Health and Social Care, what assessment he has made of the compatibility of the PATHWAYS trial with the requirement that clinical trials minimise foreseeable risks to child development.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
4 December 2025
Written question
To ask the Secretary of State for Health and Social Care, what assessment he has made of the compatibility of the PATHWAYS trial with the requirement that clinical trials minimise foreseeable risks to child development.
Source: Commons
13 January 2026
Answer
Children’s healthcare must always be evidence-led. That’s why we are following expert, independent advice from the Cass Review to implement a programme of research to support the National Health Service to provide the best support to children and young pe...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-12-04/97463
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1860719
- uk · wq-1860719 · source updated 13 January 2026